Underestimation of substance abuse in psychiatric patients by conventional hospital screening

Lisa Reidy, Patricia Junquera, Karolien Van Dijck, Bernard W Steele, Charles Nemeroff

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Psychiatric diagnosis mainly relies on behavioral signs and symptoms. Substance abuse can mimic the clinical presentation of primary psychiatric disorders and can also complicate the management of psychiatric patients. The reliability and accuracy of urine toxicology is a vital tool in the optimal treatment of these patients. Current demographics of substance abuse suggest that in addition to the most conventional drugs of abuse (e.g. cocaine, cannabis) that are of concern to treating physicians, prescription medications and new designer drugs also should be when evaluating patients who present with symptoms of psychosis/drug addiction or altered mental status. Methods: Urine samples from 220 psychiatric inpatients admitted to either an acute drug and alcohol unit or acute psychiatric unit were analyzed for drugs by the standard hospital assay (KIMS) and by a more sensitive ELISA and GC-MS basic drug screening protocol. Results: The standard hospital toxicology (KIMS) was inferior to the ELISA and GC-MS methods in terms of both assay sensitivity and in detecting a broader number of drugs. The KIMS tests failed to identify opiates and amphetamine/methamphetamine in 50% of the patients. The KIMS screen did not identify zolpidem, buprenorphine and a number of synthetic drugs of abuse including cathinone and tryptamines. Conclusion: In order to reliably identify substance abuse in patients with altered mental status in inpatient settings, analytical methodologies with adequate assay sensitivity and range to detect the vast majority of commonly abused illicit drugs and prescription medications are required for optimal clinical assessment and treatment.

Original languageEnglish
Pages (from-to)206-212
Number of pages7
JournalJournal of Psychiatric Research
Volume59
DOIs
StatePublished - Jan 1 2014

Fingerprint

Substance-Related Disorders
Psychiatry
Street Drugs
Toxicology
Opiate Alkaloids
Inpatients
Enzyme-Linked Immunosorbent Assay
Designer Drugs
Urine
Pharmaceutical Preparations
Tryptamines
Drug Prescriptions
Buprenorphine
Behavioral Symptoms
Preclinical Drug Evaluations
Methamphetamine
Amphetamine
Cannabis
Cocaine
Mental Disorders

Keywords

  • Drug testing
  • Psychiatric patients
  • Urine toxicology

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Arts and Humanities (miscellaneous)

Cite this

Underestimation of substance abuse in psychiatric patients by conventional hospital screening. / Reidy, Lisa; Junquera, Patricia; Van Dijck, Karolien; Steele, Bernard W; Nemeroff, Charles.

In: Journal of Psychiatric Research, Vol. 59, 01.01.2014, p. 206-212.

Research output: Contribution to journalArticle

@article{9d454be9977b447e8790f5f4d96173c0,
title = "Underestimation of substance abuse in psychiatric patients by conventional hospital screening",
abstract = "Psychiatric diagnosis mainly relies on behavioral signs and symptoms. Substance abuse can mimic the clinical presentation of primary psychiatric disorders and can also complicate the management of psychiatric patients. The reliability and accuracy of urine toxicology is a vital tool in the optimal treatment of these patients. Current demographics of substance abuse suggest that in addition to the most conventional drugs of abuse (e.g. cocaine, cannabis) that are of concern to treating physicians, prescription medications and new designer drugs also should be when evaluating patients who present with symptoms of psychosis/drug addiction or altered mental status. Methods: Urine samples from 220 psychiatric inpatients admitted to either an acute drug and alcohol unit or acute psychiatric unit were analyzed for drugs by the standard hospital assay (KIMS) and by a more sensitive ELISA and GC-MS basic drug screening protocol. Results: The standard hospital toxicology (KIMS) was inferior to the ELISA and GC-MS methods in terms of both assay sensitivity and in detecting a broader number of drugs. The KIMS tests failed to identify opiates and amphetamine/methamphetamine in 50{\%} of the patients. The KIMS screen did not identify zolpidem, buprenorphine and a number of synthetic drugs of abuse including cathinone and tryptamines. Conclusion: In order to reliably identify substance abuse in patients with altered mental status in inpatient settings, analytical methodologies with adequate assay sensitivity and range to detect the vast majority of commonly abused illicit drugs and prescription medications are required for optimal clinical assessment and treatment.",
keywords = "Drug testing, Psychiatric patients, Urine toxicology",
author = "Lisa Reidy and Patricia Junquera and {Van Dijck}, Karolien and Steele, {Bernard W} and Charles Nemeroff",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.jpsychires.2014.08.020",
language = "English",
volume = "59",
pages = "206--212",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Underestimation of substance abuse in psychiatric patients by conventional hospital screening

AU - Reidy, Lisa

AU - Junquera, Patricia

AU - Van Dijck, Karolien

AU - Steele, Bernard W

AU - Nemeroff, Charles

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Psychiatric diagnosis mainly relies on behavioral signs and symptoms. Substance abuse can mimic the clinical presentation of primary psychiatric disorders and can also complicate the management of psychiatric patients. The reliability and accuracy of urine toxicology is a vital tool in the optimal treatment of these patients. Current demographics of substance abuse suggest that in addition to the most conventional drugs of abuse (e.g. cocaine, cannabis) that are of concern to treating physicians, prescription medications and new designer drugs also should be when evaluating patients who present with symptoms of psychosis/drug addiction or altered mental status. Methods: Urine samples from 220 psychiatric inpatients admitted to either an acute drug and alcohol unit or acute psychiatric unit were analyzed for drugs by the standard hospital assay (KIMS) and by a more sensitive ELISA and GC-MS basic drug screening protocol. Results: The standard hospital toxicology (KIMS) was inferior to the ELISA and GC-MS methods in terms of both assay sensitivity and in detecting a broader number of drugs. The KIMS tests failed to identify opiates and amphetamine/methamphetamine in 50% of the patients. The KIMS screen did not identify zolpidem, buprenorphine and a number of synthetic drugs of abuse including cathinone and tryptamines. Conclusion: In order to reliably identify substance abuse in patients with altered mental status in inpatient settings, analytical methodologies with adequate assay sensitivity and range to detect the vast majority of commonly abused illicit drugs and prescription medications are required for optimal clinical assessment and treatment.

AB - Psychiatric diagnosis mainly relies on behavioral signs and symptoms. Substance abuse can mimic the clinical presentation of primary psychiatric disorders and can also complicate the management of psychiatric patients. The reliability and accuracy of urine toxicology is a vital tool in the optimal treatment of these patients. Current demographics of substance abuse suggest that in addition to the most conventional drugs of abuse (e.g. cocaine, cannabis) that are of concern to treating physicians, prescription medications and new designer drugs also should be when evaluating patients who present with symptoms of psychosis/drug addiction or altered mental status. Methods: Urine samples from 220 psychiatric inpatients admitted to either an acute drug and alcohol unit or acute psychiatric unit were analyzed for drugs by the standard hospital assay (KIMS) and by a more sensitive ELISA and GC-MS basic drug screening protocol. Results: The standard hospital toxicology (KIMS) was inferior to the ELISA and GC-MS methods in terms of both assay sensitivity and in detecting a broader number of drugs. The KIMS tests failed to identify opiates and amphetamine/methamphetamine in 50% of the patients. The KIMS screen did not identify zolpidem, buprenorphine and a number of synthetic drugs of abuse including cathinone and tryptamines. Conclusion: In order to reliably identify substance abuse in patients with altered mental status in inpatient settings, analytical methodologies with adequate assay sensitivity and range to detect the vast majority of commonly abused illicit drugs and prescription medications are required for optimal clinical assessment and treatment.

KW - Drug testing

KW - Psychiatric patients

KW - Urine toxicology

UR - http://www.scopus.com/inward/record.url?scp=84908338164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908338164&partnerID=8YFLogxK

U2 - 10.1016/j.jpsychires.2014.08.020

DO - 10.1016/j.jpsychires.2014.08.020

M3 - Article

C2 - 25262418

AN - SCOPUS:84908338164

VL - 59

SP - 206

EP - 212

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

SN - 0022-3956

ER -